Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: Experience of the French Langerhans Cell Study Group-Reference-Cited by-同舟云学术

Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: Experience of the French Langerhans Cell Study Group

Published:2003-06 Issue:12 Volume:31 Page:1097-1103
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Akkari V,Donadieu J,Piguet C,Bordigoni P,Michel G,Blanche S,Casanova J L,Thomas C,Vilmer E,Fischer A,Bertrand Y

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1704065.pdf

Reference15 articles.

1. Minkov M, Grois N, Heitger A et al. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group. Klin Padiatr 2000; 212: 139–144.

2. Gadner H, Grois N, Arico M et al. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr 2001; 138: 728–734.

3. The French Langerhans Cell Study Group. A multicentre retrospective survey of Langerhans cell histiocytosis: 348 cases observed between 1983 and 1993. Arch Dis Child 1996; 75: 17–24.

4. Ringden O, Ahstrom L, Lonnqvist B et al. Allogeneic bone marrow transplantation in a patient with chemotherapy-resistant progressive histiocytosis X. N Eng J Med 1987; 316: 733–735.

5. Histiocyte Society Writing Group. Histiocytosis syndrome in children. Lancet 1987; 15: 208–209.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vemurafenib combined with chemotherapy achieved sustained remission in pediatric LCH: a multi-center observational study;Journal of Cancer Research and Clinical Oncology;2024-01

2. Stem cell transplantation: A promising approach for pediatric patients with refractory multistage langerhans cell histiocytosis;Journal of Applied Hematology;2022

3. Hematopoietic stem cell transplantation for Langerhans cell histiocytosis: clinical findings and long-term outcomes;Expert Opinion on Orphan Drugs;2020-06-24

4. The influence of clinical features mimicking primary immunodeficiency diseases (mPID) on children with Langerhans cell histiocytosis (LCH) — Four with mPID among 39 LCH children from one referral center during 18-year period;Immunobiology;2020-03

5. Langerhans Cell Histiocytosis of the Gastrointestinal Tract: Evidence for Risk Organ Status;The Journal of Pediatrics;2019-09